 |
|
Treatment of
Yong-Soo Kwon, Won-Jung Koh, Charles L. Daley
Tuberc Respir Dis. 2019;82(1):15-26. Published online 2018 Dec 19 DOI: https://doi.org/10.4046/trd.2018.0060
|
|
Citations to this article as recorded by
 Trend of nontuberculous mycobacteria species and minimal inhibitory concentration in a referral laboratory in Korea from 2013 to 2019
Young Jin Kim, Seungmo Kim, Heejung Ham, Sarah Yu, Hyeon-Ju Choo, Hwi-Jun Kim, Ryeun Heo, Gyeongsik Choi, Soul-hee Kim, Hee Joo Lee
Journal of Infection and Public Health.2024; 17(2): 212. CrossRef The role of treatment regimen and duration in treating patients with Mycobacterium avium complex lung disease: A real-world experience and case–control study
Ping-Huai Wang, Chin-Chung Shu, Chung-Yu Chen, Yu-Feng Wei, Shih-Lung Cheng
Journal of Microbiology, Immunology and Infection.2024; 57(1): 164. CrossRef Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients
Hyun-Eui Park, Kyu-Min Kim, Minh Phuong Trinh, Jung-Wan Yoo, Sung Jae Shin, Min-Kyoung Shin
Annals of Clinical Microbiology and Antimicrobials.2024;[Epub] CrossRef The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease
Ju Kwang Lee, Seonok Kim, Yong Pil Chong, Hyun Joo Lee, Tae Sun Shim, Kyung-Wook Jo
CHEST.2024;[Epub] CrossRef Radiologic Subtypes and Treatment Outcome of Unclassifiable Type Mycobacterium avium Complex Pulmonary Disease
Jang Ho Lee, Yea Eun Park, Yong Pil Chong, Hyun Joo Lee, Tae Sun Shim, Kyung-Wook Jo
Journal of Korean Medical Science.2023;[Epub] CrossRef Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen
Maham Rais, Hazem Abdelaal, Valerie A. Reese, Debora Ferede, Sasha E. Larsen, Tiffany Pecor, Jesse H. Erasmus, Jacob Archer, Amit P. Khandhar, Sarah K. Cooper, Brendan K. Podell, Steven G. Reed, Rhea N. Coler, Susan L. Baldwin
Tuberculosis.2023; 138: 102302. CrossRef Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review
Tanner M. Johnson, Thomas F. Byrd, Wendi K. Drummond, Lindsey M. Childs-Kean, Monica V. Mahoney, Jeffrey C. Pearson, Christina G. Rivera
Infectious Diseases and Therapy.2023; 12(2): 343. CrossRef
In vitro
and intracellular activities of novel thiopeptide derivatives against macrolide-susceptible and macrolide-resistant
Mycobacterium avium
complex
Jiyun Park, Lee-Han Kim, Ju Mi Lee, Sangwon Choi, Young-Jin Son, Hee-Jong Hwang, Sung Jae Shin, Monika Kumaraswamy
Microbiology Spectrum.2023;[Epub] CrossRef Type 2 Diabetes Mellitus- and Complication-Related Risk of Nontuberculous Mycobacterial Disease in a South Korean Cohort
Da Som Jeon, Seonok Kim, Mi Ae Kim, Yong Pil Chong, Tae Sun Shim, Chang Hee Jung, Ye-Jee Kim, Kyung-Wook Jo, Paschalis Vergidis, Byung Woo Jhun
Microbiology Spectrum.2023;[Epub] CrossRef Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
Seong Min Kim, Yong Pil Chong, Hyun Joo Lee, Tae Sun Shim, Kyung-Wook Jo, Alexandra Aubry
Microbiology Spectrum.2023;[Epub] CrossRef Nontuberculous mycobacterial pulmonary disease in a patient with unilateral pulmonary artery agenesis: Case report
Chang-Seok Yoon, Hwa-Kyung Park, Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yong-Soo Kwon
Respiratory Medicine Case Reports.2023; 43: 101844. CrossRef Targeted and efficient delivery of rifampicin to macrophages involved in non-tuberculous mycobacterial infection via mannosylated solid lipid nanoparticles
Jayoung Chae, Seung Hyun Kang, Jiwon Kim, Yonghyun Choi, Shin Hyuk Kang, Jonghoon Choi
Nanoscale Advances.2023; 5(17): 4536. CrossRef Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection
Melissa Kelley, Kayvan Sasaninia, Arbi Abnousian, Ali Badaoui, James Owens, Abrianna Beever, Nala Kachour, Rakesh Kumar Tiwari, Vishwanath Venketaraman
Pathogens.2023; 12(8): 1057. CrossRef Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand
Auttawit Sirichoat, Orawee Kaewprasert, Yothin Hinwan, Kiatichai Faksri, Fumihiro Yamaguchi
PLOS ONE.2023; 18(11): e0294677. CrossRef Diferencias por sexo en enfermedad pulmonar causada por micobacterias diagnosticada en el INER en el período 2016-2018
Luis G Sartillo-Mendoza, Claudia A Martínez-Sanabria, Eduardo Becerril-Vargas, Yolanda González, Esmeralda Juárez
NCT Neumología y Cirugía de Tórax.2023; 82(1): 14. CrossRef Mycobacterium avium infection associated with sterile polyarthritis in a dog
S. Gelendi, S. Taylor, C. D'Aout, C. Pitchford, O. Coldrick, C. Sanchez‐Jimenez, C. O'Halloran
Journal of Small Animal Practice.2022; 63(2): 154. CrossRef Pharmacotherapy for nontuberculous mycobacterial pulmonary disease
Manasa Velagapudi, Michael J Sanley, Sumaya Ased, Chris Destache, Mark A Malesker
American Journal of Health-System Pharmacy.2022; 79(6): 437. CrossRef The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection
Catherine Weathered, Kelly Pennington, Patricio Escalante, Elsje Pienaar
Journal of Theoretical Biology.2022; 534: 110949. CrossRef Clarithromycin–Rifampin-Based Treatment for Nontuberculous Mycobacteria Infections in Immunocompromised Patients who Require Concomitant CYP-Metabolized Medications
Isabel H Gonzalez-Bocco, Muneerah M Aleissa, Eric Zhou, Jennifer Manne-Goehler, Sophia Koo, Matthew P Cheng, Francisco M Marty
Open Forum Infectious Diseases.2022;[Epub] CrossRef Disease Progression in Patients With Nontuberculous Mycobacterial Lung Disease of Nodular Bronchiectatic (NB) Pattern: The Roles of Cavitary NB and Soluble Programmed Death Protein-1
Sheng Wei Pan, Wei Juin Su, Yu Jiun Chan, Mei Lin Ho, Jia Yih Feng, Chin Chung Shu, Jann Yuan Wang, Hao Chien Wang, Chong Jen Yu, Yuh Min Chen
Clinical Infectious Diseases.2022; 75(2): 239. CrossRef Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types
Jang Ho Lee, Yea Eun Park, Yong Pil Chong, Tae Sun Shim, Kyung-Wook Jo
Antimicrobial Agents and Chemotherapy.2022;[Epub] CrossRef Treatment outcomes of the interstitial lung disease subtype of unclassifiable type Mycobacterium avium complex pulmonary disease
Yea Eun Park, Jang Ho Lee, Yong Pil Chong, Hyun Joo Lee, Ho Cheol Kim, Jin Woo Song, Tae Sun Shim, Kyung-Wook Jo
Journal of Infection and Chemotherapy.2022; 28(8): 1112. CrossRef МИКОБАКТЕРИОЗ ЛЕГКИХ: НЕРЕШЕННЫЕ ВОПРОСЫ АНТИБАКТЕРИАЛЬНОЙ ТЕРАПИИ, "Вестник Центрального научно-исследовательского института туберкулеза"
А.С. Зайцева, И.Э. Степанян, Е.И. Шмелев
Вестник ЦНИИТ.2022; (1): 6. CrossRef Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium
Gül Kilinç, Kimberley V. Walburg, Kees L. M. C. Franken, Merel L. Valkenburg, Alexandra Aubry, Mariëlle C. Haks, Anno Saris, Tom H. M. Ottenhoff
Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef Global Meta-analysis of Airborne Bacterial Communities and Associations with Anthropogenic Activities
Xiaoqing Jiang, Chunhui Wang, Jinyuan Guo, Jiaheng Hou, Xiao Guo, Haoyu Zhang, Jie Tan, Mo Li, Xin Li, Huaiqiu Zhu
Environmental Science & Technology.2022; 56(14): 9891. CrossRef Drug‐level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients
Ock‐Hwa Kim, Tae Sun Shim, Kyung‐Wook Jo
Transplant Infectious Disease.2022;[Epub] CrossRef The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea
Sang Hyuk Kim, Byung Woo Jhun, Byeong-Ho Jeong, Hye Yun Park, Hojoong Kim, O Jung Kwon, Sun Hye Shin
Journal of Korean Medical Science.2022;[Epub] CrossRef Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease
Ganghee Chae, Yea Eun Park, Yong Pil Chong, Hyun Joo Lee, Tae Sun Shim, Kyung-Wook Jo
Antimicrobial Agents and Chemotherapy.2022;[Epub] CrossRef EGZOTİK (YABANİ) HAYVANLARDAN KAYNAKLI ZOONOZLAR VE SAĞALTIMI
Emre ARSLANBAŞ, Emine BAYDAN
Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni.2022; 13(2): 78. CrossRef Antimicrobial susceptibility of Mycobacterium avium complex mycobacteria isolated from patients in Ural Federal District of the Russian Federation
Tatiana V. Umpeleva, M.V. Shulgina, Diana V. Vakhrusheva, N.I. Eremeeva
Clinical Microbiology and Antimicrobial Chemotherapy.2022; 24(2): 147. CrossRef Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection
Hyun-Eui Park, Wonsik Lee, Sangwon Choi, Myunghwan Jung, Min-Kyoung Shin, Sung Jae Shin
Frontiers in Immunology.2022;[Epub] CrossRef Variability of Mycobacterium avium Complex Isolates Drug Susceptibility Testing by Broth Microdilution
Danila Zimenkov
Antibiotics.2022; 11(12): 1756. CrossRef Mycobacterial immunevasion—Spotlight on the enemy within
Anne Kathrin Lösslein, Philipp Henneke
Journal of Leukocyte Biology.2021; 109(1): 9. CrossRef Elevated serum antibody responses to synthetic mycobacterial lipid antigens among UK farmers: an indication of exposure to environmental mycobacteria?
Alison Jones, Carys A. Davies, Samuel Fitch, Juma'a R. Al Dulayymi, Christopher D. Gwenin, James Gibbons, A. Prysor Williams, Mark S. Baird
RSC Medicinal Chemistry.2021; 12(2): 213. CrossRef First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
Kiyoharu Fukushima, Seigo Kitada, Sho Komukai, Tomoki Kuge, Takanori Matsuki, Hiroyuki Kagawa, Kazuyuki Tsujino, Mari Miki, Keisuke Miki, Hiroshi Kida
Scientific Reports.2021;[Epub] CrossRef Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease
Dong-Woo Han, Kyung-Wook Jo, Ock-Hwa Kim, Tae Sun Shim
Respiratory Medicine.2021; 179: 106340. CrossRef Trends in the Nontuberculous Mycobacterial Disease Mortality Rate in Japan: A Nationwide Observational Study, 1997–2016
Ko Harada, Hideharu Hagiya, Tomoko Funahashi, Toshihiro Koyama, Mitsunobu R Kano, Fumio Otsuka
Clinical Infectious Diseases.2021; 73(2): e321. CrossRef МИКОБАКТЕРИОЗЫ ОРГАНОВ ДЫХАНИЯ В МЕГАПОЛИСЕ:, "Вестник Центрального научно-исследовательского института туберкулеза"
Л.Д. Гунтупова, С.Е. Борисов
Вестник ЦНИИТ.2021; (1): 38. CrossRef Role of Clofazimine in Treatment of Mycobacterium avium Complex
Mohammad Javad Nasiri, Tess Calcagno, Sareh Sadat Hosseini, Ali Hematian, Neda Yousefi Nojookambari, Mohammadmahdi Karimi-Yazdi, Mehdi Mirsaeidi
Frontiers in Medicine.2021;[Epub] CrossRef Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan
Asifa Karamat, Atiqa Ambreen, Aamira Ishtiaq, Sabira Tahseen, Muhammad Aqeelur Rahman, Tehmina Mustafa
BMC Infectious Diseases.2021;[Epub] CrossRef Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models
Sasha E. Larsen, Valerie A. Reese, Tiffany Pecor, Bryan J. Berube, Sarah K. Cooper, Guy Brewer, Diane Ordway, Marcela Henao-Tamayo, Brendan K. Podell, Susan L. Baldwin, Rhea N. Coler
Scientific Reports.2021;[Epub] CrossRef Donor-Defined Mesenchymal Stem Cell Antimicrobial Potency Against Nontuberculous Mycobacterium
Tracey L. Bonfield, Morgan T. Sutton, David R. Fletcher, Michael A. Folz, Vaishnavi Ragavapuram, Rodrigo A. Somoza, Arnold I. Caplan
Stem Cells Translational Medicine.2021; 10(8): 1202. CrossRef Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection
Yang Zhang, Adam T Hill
Expert Review of Respiratory Medicine.2021; 15(6): 737. CrossRef Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease
David E. Griffith, Rachel Thomson, Patrick A. Flume, Timothy R. Aksamit, Stephen K. Field, Doreen J. Addrizzo-Harris, Kozo Morimoto, Wouter Hoefsloot, Kevin C. Mange, Dayton W. Yuen, Monika Ciesielska, Richard J. Wallace, Jakko van Ingen, Barbara A. Brown
Chest.2021; 160(3): 831. CrossRef Population Pharmacokinetic Analysis of Bedaquiline‐Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study
Ken Kurosawa, Stefaan Rossenu, Jeike Biewenga, Sivi Ouwerkerk‐Mahadevan, Wouter Willems, Etienne Ernault, Chrispin Kambili
The Journal of Clinical Pharmacology.2021; 61(10): 1344. CrossRef DNA Methylation Profiling for the Diagnosis and Prognosis of Patients with Nontuberculous Mycobacterium Lung Disease
Jee Youn Oh, Young Kyung Ko, Jeong-An Gim
Current Issues in Molecular Biology.2021; 43(2): 501. CrossRef Nontuberculous Mycobacteria in Humans, Animals, and Water in Zambia: A Systematic Review
Mildred Zulu, Ngula Monde, Panji Nkhoma, Sydney Malama, Musso Munyeme
Frontiers in Tropical Diseases.2021;[Epub] CrossRef Nanoparticulate β-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against Mycobacteroides abscessus and Mycobacterium avium
Seoung-Ryoung Choi, Geoffrey A. Talmon, Bradley E. Britigan, Prabagaran Narayanasamy
ACS Infectious Diseases.2021; 7(8): 2299. CrossRef Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments
Jakko van Ingen, Marko Obradovic, Mariam Hassan, Beth Lesher, Erin Hart, Anjan Chatterjee, Charles L. Daley
Expert Review of Respiratory Medicine.2021; 15(11): 1387. CrossRef Comparative Genomics of Mycobacterium avium Complex Reveals Signatures of Environment-Specific Adaptation and Community Acquisition
Eric C. Keen, JooHee Choi, Meghan A. Wallace, Michelle Azar, Carlos R. Mejia-Chew, Shail B. Mehta, Thomas C. Bailey, Lindsay J. Caverly, Carey-Ann D. Burnham, Gautam Dantas, Jack A. Gilbert
mSystems.2021;[Epub] CrossRef
In vitro activity of bedaquiline against Mycobacterium avium complex
Vitaly Litvinov, Marina Makarova, Dmitry Kudlay, Nikolai Nikolenko, Julia Mikhailova
Journal of Medical Microbiology
.2021;[Epub] CrossRef Case Report: Kampo Medicine for Non-tuberculous Mycobacterium Pulmonary Disease
Tomoko Suzuki, Kazushi Uneda, Ryutaro Aoyagi, Takehito Kobayashi, Tadamichi Mitsuma, Hidetomo Nakamoto
Frontiers in Nutrition.2021;[Epub] CrossRef Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events inMycobacterium aviumComplex Lung Disease
Yong Shik Kwon, Byoung Soo Kwon, Ock-hwa Kim, Yea Eun Park, Tae Sun Shim, Yong Pil Chong, Kyung-Wook Jo
Journal of Korean Medical Science.2020;[Epub] CrossRef Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease
Sung Woo Moon, Eun Hye Lee, Ji Soo Choi, Ah Young Leem, Su Hwan Lee, Sang Hoon Lee, Song Yee Kim, Kyung Soo Chung, Ji Ye Jung, Moo Suk Park, Young Sam Kim, Young Ae Kang, Abdelwahab Omri
PLOS ONE.2020; 15(5): e0232714. CrossRef Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis
Mohammad Javad Nasiri, Golnaz Ebrahimi, Samaneh Arefzadeh, Samin Zamani, Zahra Nikpor, Mehdi Mirsaeidi
Expert Review of Anti-infective Therapy.2020; 18(3): 263. CrossRef Treatment for Mycobacterium avium complex lung disease
Sheng-Wei Pan, Chin-Chung Shu, Jia-Yih Feng, Wei-Juin Su
Journal of the Formosan Medical Association.2020; 119: S67. CrossRef
Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of
Mycobacterium avium
Infection
Jean-Philippe Lanoix, Cédric Joseph, François Peltier, Sandrine Castelain, Claire Andréjak
Antimicrobial Agents and Chemotherapy.2020;[Epub] CrossRef Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: A propensity score analysis
Yong Shik Kwon, Minkyu Han, Byoung Soo Kwon, Ock-Hwa Kim, Ho-Young Lee, Tae Sun Shim, Yong Pil Chong, Kyung-Wook Jo
Journal of Global Antimicrobial Resistance.2020; 22: 106. CrossRef Changes in chest X-ray findings in 1- and 2-month group after treatment initiation for suspected pulmonary tuberculosis
Jang Ho Lee, Ock-Hwa Kim, Yeon Joo Kim, Tae Sun Shim, Kyung-Wook Jo
The Korean Journal of Internal Medicine.2020; 35(5): 1145. CrossRef Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease
Kyung-Wook Jo, Yea Eun Park, Yong Pil Chong, Tae Sun Shim, Yoshihiko Hoshino
PLOS ONE.2020; 15(4): e0232161. CrossRef The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults Omer Khan, Nauman Chaudary
Drug Design, Development and Therapy.2020; Volume 14: 2287. CrossRef Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients
Claire E Hannah, Bradley A Ford, Jina Chung, Dilek Ince, Karolyn A Wanat
Open Forum Infectious Diseases.2020;[Epub] CrossRef Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment
Ping-Huai Wang, Sheng-Wei Pan, Chin-Chung Shu, Chung-Yu Chen, Yu-Feng Wei, Shih-Lung Cheng, Hao-Chien Wang, Chong-Jen Yu
Respiratory Medicine.2020; 171: 106070. CrossRef Cytomorphology of Mycobacterium avium intracellulare‐associated ascites
Swati Satturwar, Liron Pantanowitz, Juan Xing, Karen Schoedel, David Weber, Sara E. Monaco
Diagnostic Cytopathology.2020;[Epub] CrossRef Short-Chain Fatty Acids Promote Mycobacterium avium subsp. hominissuis Growth in Nutrient-Limited Environments and Influence Susceptibility to Antibiotics
Carlos Adriano de Matos e Silva, Rajoana Rojony, Luiz E. Bermudez, Lia Danelishvili
Pathogens.2020; 9(9): 700. CrossRef Evaluation of Disulfiram Drug Combinations and Identification of Other More Effective Combinations against Stationary Phase Borrelia burgdorferi
Hector Alvarez-Manzo, Yumin Zhang, Wanliang Shi, Ying Zhang
Antibiotics.2020; 9(9): 542. CrossRef European Respiratory Society International Congress, Madrid, 2019: nontuberculous mycobacterial pulmonary disease highlights
James D. Chalmers, Charlotte Balavoine, Paola F. Castellotti, Christian Hügel, Annabelle Payet, Dennis Wat, Gernot Rohde
ERJ Open Research.2020; 6(4): 00317-2020. CrossRef Exposure of Mycobacterium avium subsp. homonissuis to Metal Concentrations of the Phagosome Environment Enhances the Selection of Persistent Subpopulation to Antibiotic Treatment
Lia Danelishvili, Elyssa Armstrong, Emily Miyasako, Brendan Jeffrey, Luiz E. Bermudez
Antibiotics.2020; 9(12): 927. CrossRef Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis
Youngmok Park, Eun Hye Lee, Inkyung Jung, Goeun Park, Young Ae Kang
Respiratory Research.2019;[Epub] CrossRef Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches
Yong-Soo Kwon, Charles L. Daley, Won-Jung Koh
Expert Review of Respiratory Medicine.2019; 13(9): 851. CrossRef The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease
Byoung Soo Kwon, Jun Hee Lee, Younsuck Koh, Woo-Sung Kim, Jin-Woo Song, Yeon-Mok Oh, Sang-Do Lee, Sei Won Lee, Jae-Seung Lee, Chae-Man Lim, Chang-Min Choi, Jin-Won Huh, Sang-Bum Hong, Tae Sun Shim, Kyung-Wook Jo
Respiratory Medicine.2019; 150: 45. CrossRef Reply to Aubry and Veziris: Smear Microscopy Complements Xpert MTB/RIF When Considering Nontuberculous Mycobacterial Infections
Hyun-Woo Choi, Ju-Hyeon Shin, Seung-Jung Kee, Yong-Soo Kwon, Taeo Ma, Hyun-Seung Lee, Sejong Chun, Eun Jeong Won, Jong-Hee Shin
American Journal of Respiratory and Critical Care Medicine.2019; 200(8): 1073. CrossRef Recent advances in nontuberculous mycobacterial lung infections
David Horne, Shawn Skerrett
F1000Research.2019; 8: 1710. CrossRef
In Vitro
Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
Dae Hun Kim, Byung Woo Jhun, Seong Mi Moon, Su-Young Kim, Kyeongman Jeon, O Jung Kwon, Hee Jae Huh, Nam Yong Lee, Sung Jae Shin, Charles L. Daley, Won-Jung Koh
Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef
|